Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.

Breast Cancer Res Treat · 2019 · PMC6534526 · PMID 30868392

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

In the multivariable analyses with correction for hormonal status, the effect of CD8+ infiltrate on pCR was still significant and the effect of HLA class 1 status borderline significant.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.